PI3K/AKT-IN-6
PI3K/AKT-IN-6 is an orally effective PI3K/AKT signaling pathway inhibitor and anti-inflammatory agent. PI3K/AKT-IN-6 inhibits the production of pro-inflammatory cytokines TNF-α and IL-6, and downregulates the expression of inflammatory mediators COX-2 and iNOS. PI3K/AKT-IN-6 improves related symptoms in colitis mice. PI3K/AKT-IN-6 can be used for the research of inflammatory diseases such as colitis.
For research use only. We do not sell to patients.
- Formula: C23H25Cl2FN2O5
- Molecular Weight:499.36
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
COX-2 |
IL-6 |
In Vitro
PI3K/AKT-IN-6 (compound 110) (10 μM) inhibits LPS (HY-D1056)-induced NO production in RAW 264.7 macrophages without significant cytotoxicity[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6J treated DSS (22-25 g)[1]
-
Dosage:20 mg/kg
-
Administration:p.o.; daily; 7 days
-
Result:Reduced mean body weight loss, with body weigh.
Reduced disease activity index (DAI).
Reduced serum TNF-α, IL-6 levels.
Reduced iNOS/GAPDH, COX-2/GAPDH, p-PI3K/PI3K, p-AKT/AKT ratio in colonic tissue.
Reduced inflammatory cell infiltration and improved goblet cell damage in colon tissue.
Chemical Information
-
Molecular Weight 499.36
-
Formula C23H25Cl2FN2O5
-
SMILES
O[C@@H]1C=C(C(NC23C[C@@H](C4)C[C@H](C3)CC4C2)=O)C[C@@H](OC(C5=C(Cl)N=C(Cl)C(F)=C5)=O)[C@@H]1O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)